Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Carole Creuzenet

The University of Western Ontario, Canada

Title: Disulfide bond formation in gastric pathogen Helicobacter pylori: An Achillae’s heel for secretion of pro-inflammatory virulence proteins

Biography

Biography: Carole Creuzenet

Abstract

H. pylori causes gastritis, gastric ulcers and cancers but the mechanisms of virulence are not fully understood. It produces secreted proteins which may play a role in eliciting gastric inflammation, including the helicobacter cysteine rich protein HcpE (HP0235) whose biological function is unknown. Our goal was to investigate if HcpE is secreted by H. pylori and is involved in host/pathogen interactions, and identify components essential for its production. Using a combination of anti-HcpE ELISA and western blots, knockout mutagenesis, phenotypic analyses and biochemical assays, we demonstrate that HcpE is secreted by many strains as a soluble protein and in association with outer membrane vesicles. We show that infected patients produce anti-HcpE antibodies, indicating in situ HcpE production. We show that HcpE comprises many disulfide bonds and identify DsbK (HP0231) as a folding factor necessary for HcpE production, and show that recombinant DsbK can refold unprocessed, reduced HcpE in vitro. This highlights the first biologically relevant substrate for DsbK. Furthermore, we show that DsbK has disulfide bond (Dsb) forming activity on reduced lysozyme and has DsbA-like activity upon expression in E. coli, despite its similarity with DsbG. Also, we show a role of DsbK in redox homeostasis in H. pylori. Finally, we show an important role for DsbK and HcpE in host-pathogen interactions, including murine gastric colonization and pro-inflammatory cytokine production in human gastric explants and in murine splenocytes. Both proteins will be investigated as therapeutic targets to treat H. pylori infections and prevent gastric ulcers and cancers.

Speaker Presentations

Speaker PPTs Click Here